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I nduction of venous blood return to the venous reser-voir during cardiac surgery is typically initiated by a
gravity siphon and maintained by the height of the
patient with respect to the venous reservoir. With the
introduction of minimally invasive techniques, howev-
er, peripheral cannulation and smaller venous cannulas
have increased the resistance to venous blood flow and
have necessitated the use of augmented venous return
techniques. These augmented drainage systems can be
either vacuum-augmented venous return or kinetically
augmented venous return. Both of these systems create
a large negative pressure in the venous line, either
through vacuum assistance or by a pump added to the
Objectives: The proliferation of minimally invasive cardiac surgery has
increased dependence on augmented venous return techniques for car-
diopulmonary bypass. Such augmented techniques have the potential to
introduce venous air emboli, which can pass to the patient. We examined the
potential for the transmission of air emboli with different augmented venous
return techniques.
Methods: In vitro bypass systems with augmented venous drainage were cre-
ated with either kinetically augmented or vacuum-augmented venous return.
Roller or centrifugal pumps were used for arterial perfusion in combination
with a hollow fiber oxygenator and a 40-µm arterial filter. Air was intro-
duced into the venous line via an open 25-gauge needle. Test conditions
involved varying the amount of negative venous pressure, the augmented
venous return technique, and the arterial pump type. Measurements were
recorded at the following sites: pre-arterial pump, post-arterial pump, post-
oxygenator, and patient side.
Results: Kinetically augmented venous return quickly filled the centrifu-
gal venous pump with macrobubbles requiring continuous manual clear-
ing; a steady state to test for air embolism could not be achieved. Vacuum-
augmented venous return handled the air leakage satisfactorily and
microbubbles per minute were measured. Higher vacuum pressures result-
ed in delivery of significantly more microbubbles to the “patient”
(P < .001). The use of an arterial centrifugal pump was associated with
fewer microbubbles (P = .02). 
Conclusions: Some augmented venous return configurations permit a signif-
icant quantity of microbubbles to reach the patient despite filtration. A cen-
trifugal pump has air-handling disadvantages when used for kinetic venous
drainage, but when used as an arterial pump in combination with vacuum-
assisted venous drainage it aids in clearing air emboli. (J Thorac Cardiovasc
Surg 2000;120:856-63)
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venous circuit. Creation of a subatmospheric pressure
increases the venous pressure gradient between the
patient and the venous inlet of the pump circuit and
allows satisfactory flow to be maintained through
smaller, high-resistance cannulas. As a result of these
augmented systems, venous return can be increased
without the need to raise the patient’s height with
respect to the venous reservoir.
Recently it has been shown that augmented venous
return techniques may help to introduce gaseous
microemboli into the patient undergoing cardiopul-
monary bypass (CPB).1 Although many potential caus-
Fig 1.  A, Vacuum-augmented venous return CPB circuit. *Arterial pump was alternated between roller and cen-
trifugal for each part of the experiment. HSVR, Affinity hard shell venous reservoir. B, Kinetically augmented
venous return CPB circuit. *Arterial pump was alternated between roller and centrifugal for each part of the exper-
iment. Soft-Shell, Soft shell venous reservoir.
A
B
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Fig 2. Total microbubbles at different CPB circuit sites for all vacuum levels. Pre-Art., Pre-arterial, Post-Art., post-
arterial; Post-oxy, post-oxygenator. *Statistically significant overall effect of arterial pump type.
es for gaseous emboli during CPB have been identified
(Table I),2 the creation of a negative pressure in the
venous line facilitates entrapment of air around the
venous cannula, possibly increasing gaseous microem-
boli. This is of concern, since emboli, whether blood,
foreign material, or gaseous, are believed to be respon-
sible for the neurocognitive impairment that some
patients experience after CPB.2
In this experimental series, we compared the poten-
tial for gaseous microembolus formation and transmis-
sion with the use of augmented venous return systems.
Concomitantly, we evaluated the gaseous microembo-
lus handling capabilities of various clinical augmented
venous return CPB circuits.
Materials and methods 
Four in vitro experimental CPB circuits were constructed
with 13-mm (3⁄8-inch) diameter tubing. All of the individual
circuits were constructed of new components consisting of
the following basic elements: (1) a patient simulating reser-
voir (HSVR shell, Affinity NT 541; Medtronic, Inc,
Minneapolis, Minn), (2) an augmented venous return sys-
tem, (3) an arterial pump, (4) a hollow fiber membrane oxy-
genator (Affinity NT 541; Medtronic), (5) a 40-µm arterial
line filter (model M40; Medtronic), and (6) an arterial line
that led back to the patient reservoir (outer shell of HSVR,
Affinity NT 541; Medtronic). The arterial pump was either
a roller pump (Sarns, Inc, Ann Arbor, Mich) or a centrifugal
pump (BP-80; Medtronic). The augmented venous return
systems consisted of either vacuum or kinetic assistance. In
the vacuum-augmented venous return system, a hard-shell
venous reservoir (Affinity; Medtronic) was connected to a
vacuum regulator system, which controlled the amount of
negative pressure applied to the system (Fig 1, A). In the
kinetically augmented venous return system, a centrifugal
pump (BP-80) was incorporated into the venous line
between the venous cannula and a soft-shell venous reser-
voir (MVR 1600; Medtronic) (Fig 1, B).
After the circuits had been flushed with carbon dioxide,1,3
Ringer’s solution was used as a prime. The circuits were at
room temperature and no gas flow was placed through the
membrane oxygenator. Test conditions included steady-state
flows of 5 L/min with a pinch clamp on the arterial line
before the “patient.” The clamp produced a 100–mm Hg gra-
dient (mimicking the gradient seen across an arterial cannu-
la). The arterial filter was oriented properly and its purge line
was left open. A venous line pinch clamp was used to regu-
late the return from the “patient” and to maintain the venous
Table I.  Known causes of gaseous microemboli with-










Injections into the circuit
Mechanical manipulations of the circuit
Modified from Kurusz M, Butler BD. Embolic events and cardiopulmonary
bypass (page 274). In: Gravlee GP, Davis RP, Utley JR, editors.
Cardiopulmonary bypass: principles and practice. Baltimore: Williams &
Wilkins; 1993:267-290.
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Fig 3. A, Effect of arterial pump type and vacuum pressure on microbubbles 50 µm or less in diameter after arter-
ial cannula. *Statistically significant overall effect of vacuum pressure. **Statistically significant overall effect of
arterial pump type. B, Effect of arterial pump type and vacuum pressure on microbubbles 50 to 100 µm in diame-
ter after arterial cannulation. *Statistically significant overall effect of vacuum pressure. **Statistically significant
overall effect of arterial pump type. C, Effect of arterial pump type and vacuum pressure on microbubble flow after
arterial cannula. *Statistically significant overall effect of vacuum pressure. **Statistically significant overall effect
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reservoir level at approximately 300 to 400 mL while the
“patient” shell was maintained at a level of 800 to 1000 mL. 
After baseline measurements had been established with
varying degrees of venous assistance (–15 mm Hg, –45 mm
Hg, and –75 mm Hg), air was allowed into the venous line by
simply inserting an open-ended 25-gauge hypodermic needle
into the venous tubing. The 25-gauge needle was chosen for its
dramatic demonstration of gaseous macroemboli and
microembolus entrapment with augmented venous return. This
corresponds to a small tear from a suture in the atrial cannula-
tion site, which allows air entry. Air emboli were recorded in
various parts of the circuit by the use of a snap-on ultrasound
probe with the aid of a coupling gel and a CMD-10 ultrasonic
detector (Hatteland Instrumentering, Norway). The size and
number of microbubbles, ranging from 20 to 300 µm in diam-
eter, could thereby be quantified.4,5 The CMD-10 detector,
with the aid of a computer program, BUBMON Software
(Hatteland Instrumentering, Norway), applied a deconvolution
filter to the raw data and generated histograms of bubble size.
Microbubbles were quantified at 5 different locations in the
CPB circuit (venous inlet, pre-arterial pump, pre-oxygenator,
pre-filter, and patient side) for each experimental condition.
When bubbles were visually detected, quantification was
impossible due to the bubble size limitation of the detector sys-
tem. At the pre-arterial and post-arterial pump measurement
sites, the bubble counter required a lower sensitivity due to the
large number and size of bubbles. The post-oxygenator and
“patient” sites were recorded on the identical maximum sensi-
tivity scale to allow for direct comparison and evaluation of
bubbles as small as 20 µm in diameter. 
The number and size of microbubbles were measured for
60-second intervals, and these measurements were repeated a
minimum of 6 times for each experimental condition at the
specified location. The method of venous drainage was ran-
domized for each circuit. The volumes of bubbles were cor-
rected for line pressures and were reported for 1 atmosphere
of pressure. The statistical software package SPSS (SPSS,
Inc, Chicago, Ill) was used to analyze the data. Analysis of
variance and general linear models modules (SPSS) were
used to test for differences due to the test conditions. The
Bonferroni method was used for subgroup comparisons. Data
are reported as mean ± standard error.
Results
In the first part of the experiment, we evaluated the
gaseous microembolus handling abilities of the kineti-
cally augmented venous return circuit. With the contin-
uous entrainment of air in the venous line, the venous
centrifugal pump and reservoir continuously filled with
both macrobubbles and microbubbles and required con-
stant manual clearing. This prevented achievement of
steady-state conditions and did not permit appropriate
measurements with the CMD-10 ultrasonic detector.
The second experimental series was performed with
vacuum-augmented venous return. This pump setup
was able to clear the macrobubbles, and steady-state
conditions were achieved, that is, no macrobubbles
were visualized ahead of the arterial pump. With the
steady-state flow of 5 L/min, the line pressures in the
CPB circuit were 215 mm Hg after the arterial pump,
113 mm Hg after the oxygenator, and 100 mm Hg after
the 37-µm filter.
The data measurements obtained at the preset loca-
tions and vacuum pressures of the various vacuum-aug-
mented venous return circuits are presented in Table II.
With either arterial pump, an increased negative vacu-
um pressure was associated with an increase in the
number of bubbles per minute seen at the different
measuring points (covariate effect of negative pressure
F value = 6.20; P = .01). For the measurements pre-
arterial and post-arterial pump, the great number and
size of microbubbles necessitated measurement on a
less sensitive scale, which undercounts smaller sized
bubbles. However, the recordings made post-oxygena-
tor and in the “patient” were done at the maximum sen-
sitivity of the bubble counter, eliminating the possibil-
ity of this type of underestimation. Fig 2 graphically
compares the handling of gaseous microemboli accord-
ing to the arterial pump type. The centrifugal arterial
pump was associated with lower counts per minute at
the sites beyond the pump (overall effect of arterial
Table II.  Total microbubbles (mean counts per minute ± SD) with a 25-gauge needle in the venous line and 
vacuum-augmented venous return
Arterial roller pump*
Measure site –15 mm Hg† –45 mm Hg† –75 mm Hg†
PAP‡ 1933.4 ± 1838.7 (1716.0) 1301.4 ± 729.5 (1009.5) 3081.4 ± 2104.6 (2759.5)
PoAP‡ 1983.4 ± 1891.4 (1767.0) 1187.6 ± 747.5 (1166.5) 2317.1 ± 1571.7 (2111.5)
PO 89.0 ± 20.8 (85.0) 159.3 ± 81.3 (145.5) 1334.0 ± 121.2 (1368.0)
PS 32.5 ± 16.7 (28.5) 76.7 ± 41.8 (76.5) 103.8 ± 23.7 (95.5)
SD, Standard deviation; PAP, pre-arterial pump; PoAP, post-arterial pump; PO, post-oxygenator; PS, patient side. Figures in parentheses indicate medians.
*Main effect of arterial pump type (contrasted to pre-arterial pump values) F = 9.51; P = .002. 
†Covariate effect of negative pressure F = 6.20; P = .01.
‡Counts per minute made with less sensitive settings due to high number and size of counts. 
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pump contrasted to pre-arterial pump values, F = 9.51;
P = .002). Both the oxygenator (P < .001) and arterial
filter (P < .001) removed significant gaseous microem-
boli from the circuit.
These test circuits revealed a mean of 45.4 ± 35.1
microbubbles per minute reaching the “patient,” estimat-
ed at a mean covariate of –45–mm Hg vacuum. The his-
tograms in Fig 3, A and B, depict the numbers and sizes
of bubbles reaching the patient. The mean counts
increased with higher negative vacuum pressures (P <
.001) and diminished with use of an arterial centrifugal
pump (P = .02). Fig 3, A, depicts the distribution of 20-
to 50-µm bubbles, whereas Fig 3, B, depicts the distrib-
ution of 50- to 100-µm bubbles. No bubbles larger than
100 µm were seen to reach the patient. Fig 3, C, shows
the flow of microbubbles (mean 0.0013 ± 0.0002
mL/min) reaching the patient. Significant increases were
associated with increasing negative vacuum pressure 
(P < .001) and use of an arterial roller pump (P = .01).
Discussion
Air emboli can enter a patient’s venous or arterial cir-
culation during almost any type of surgical procedure.6
Detection of these gaseous microemboli is extremely
important in patients undergoing cardiac surgery with
CPB because these emboli have been implicated as
major factors in the postoperative neuropsychologic
deficits experienced by some of these patients.7 Air
originating from the CPB circuit has been found to con-
tribute to the formation of gaseous microemboli.8-11
Modifications of the CPB circuit to accommodate
minimally invasive cardiac surgical procedures have
increased the need for the operative team to under-
stand the formation and handling of gaseous
microemboli by the different components of the CPB
circuit.1,12,13 These modifications include the addi-
tion of augmented venous return to compensate for
the increased flow resistance in the smaller cannulas
being used. The two major types of augmented
venous return techniques used clinically include
kinetic and vacuum-assisted drainage (Fig 1).
Importantly, in this study both of these techniques
resulted in significant amounts of air introduction
when a hole was present in the venous circuit. In the
first experimental series (kinetic technique), the
venous centrifugal pump was unable to handle the
delivered volume load of continuous gaseous
microemboli due to a small continuous air leak,
requiring constant manual clearing of the pump and
soft reservoir. Certainly this would not be ideal for
routine clinical practice.
In the next experimental series, vacuum-augmented
venous return configurations satisfactorily handled
the macroscopic air entrainment. Despite the pres-
ence of a standard 40-µm arterial filter, however,
gaseous microemboli were consistently delivered to
the patient in the setting of a small “air leak” before
the venous inlet. This delivery of gaseous microem-
boli was increased by higher negative vacuum pres-
sures and diminished with the use of a centrifugal
pump in the arterial position as compared with a
roller pump. Of note is the fact that gaseous
microemboli larger than 50 µm consistently were
delivered to the patient with the combination of high-
er vacuum and arterial roller pump use. Although the
absolute clinical relevance is unknown, this combina-
tion should be avoided if possible.
Similarly, Willcox, Mitchell, and Gorman1 recently
examined the effect of vacuum-augmented venous
return on venous air entrained in the CPB circuit,
demonstrating a 10-fold increase in gaseous microem-
boli with the addition of constant vacuum assist (–60
mm Hg). However, this study had several methodolog-
ic limitations. A dedicated microbubble counter was
not used but, rather, a general-purpose 2-MHz pulsed
wave color Doppler ultrasonogram. This device report-
Arterial centrifugal pump*
–15 mm Hg† –45 mm Hg† –75 mm Hg†
859.5 ± 511.1 (665.5) 1245.6 ± 508.5 (1037.0) 2188.7 ± 1683.2 (1285.5)
273.8 ± 114.8 (257.0) 443.3 ± 126.1 (426.0) 2530.6 ± 1433.0 (2259.5)
56.5 ± 14.7 (55.0) 249.8 ± 48.1 (242.0) 439.8 ± 114.5 (411.0)
7.5 ± 9.3 (5.5) 31.2 ± 16.2 (26.0) 56.5 ± 36.4 (42.0)
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ed an “index” of bubble counts and was unable to dif-
ferentiate among the sizes of bubbles. Without a decon-
volution filter, undercounting by “masking” of bubbles
occurred. Additionally, only a simple roller pump was
tested as a possible factor in gaseous microemboli
delivered to the “patient.” It has been demonstrated pre-
viously that certain centrifugal pumps function effec-
tively as air microfilters, effectively removing air
microbubbles larger than 20 µm.5
Other components of the CPB circuit in addition to
the arterial pump type are important in generation or
elimination of gaseous microemboli. Hollow fiber oxy-
genators are known to have definite advantages over
bubble oxygenators in the avoidance of gaseous
microemboli. An inverse relationship exists between
gaseous microemboli in the arterial blood and pore size
of the bubble oxygenator, with a compromise of oxy-
genation and carbon dioxide elimination associated
with smaller pore sizes.10 Therefore, we excluded test-
ing oxygenator type as a possible factor in our experi-
mental series. Additionally, venous reservoir mainte-
nance is associated with the introduction of gaseous
microemboli into the CPB circuit. Running venous
reservoirs below certain levels is associated with
increased gaseous microemboli.8 In the present study,
in the test circuits the venous reservoir levels were held
constant to compensate for this factor. A lower level
was deliberately chosen to emulate a typical clinical
scenario. 
Limitations of this study
A possible limitation of our study is the choice of a
blood- and albumin-poor solution for our experimental
circuits. Although this solution cannot be directly clin-
ically correlated, we chose this fluid to eliminate the
effects of blood protein denaturation and coating of the
microbubbles, which can be responsible for bubble
underestimation by ultrasonic Doppler techniques.14
Another possible limitation is that we did not have gas
flow through the hollow fiber membrane. Since we
were studying gas microemboli from the venous sys-
tem and gaseous microemboli do not originate from
membrane oxygenators,10 this should not be of conse-
quence in our experiment. 
In summary, assisted venous drainage techniques are
associated with an increased risk of gaseous microem-
boli. In the presence of small constant venous air
entrainment, vacuum-augmented venous return is supe-
rior to kinetically augmented venous return. When
assisted venous drainage techniques are used, a cen-
trifugal arterial pump enhances the removal of signifi-
cant gaseous microemboli that may occur despite stan-
dard arterial filter precautions. 
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Discussion
Dr Verdi DiSesa (Chicago, Ill). I have a question about the
first conclusion in your summary slide, which indicates an
increased risk of gaseous microemboli when assisted circula-
tion is used. To be fair, would it not be necessary to do the
heparin coating was minimized. We did not use cardiotomy
suction and a cell salvage device in this experiment.
Dr Craig R. Smith (New York, NY). Do you have an opin-
ion as to what constitutes a clinically relevant number or size
of bubbles? 
Dr LaPietra. The literature seems to favor microbubbles
greater than 100 µm as being clinically significant.
However, we have no clinical data to verify this number. In
our experiment, some of our designs allowed for bubbles
50 to 100 µm to pass to the patient side of the circuit. The
significance of these sizes is not yet clear. I believe that
some neurocognitive studies with respect to bubble sizes
need to be evaluated clinically to determine whether there
actually is a critical size.
Dr Edward D. Verrier (Seattle, Wash). Clinically, has air
caused any difficulties? Vacuum-assisted systems have been
used for a long time at the Cleveland Clinic, but I do not
know whether any problems have been encountered. Our per-
fusionists at the University of Washington have not noticed
any problems with centrifugal pumps, and we are sensitive to
difficulties caused by air in the system. We have not used
roller pumps. I am curious about whether this is a clinical
problem or just a warning for us to be very careful in setting
up our systems. 
Dr LaPietra. From our perspective, it is basically a warn-
ing on how the circuit is constructed. In our practice, we are
currently using vacuum-augmented venous return with an
arterial centrifugal pump, and we have not experienced any
problems either. However, on the basis of these findings, we
believe the use of an arterial roller pump with the addition of
vacuum-assisted venous drainage needs to be cautioned.
Obviously, the perfusionist plays a major role in circuit
design and setup. However, it behooves us as surgeons to
know the components and types of circuits being used clini-
cally to prevent any neurologic complications that could
occur during CPB.
Dr Verrier. Would you recommend a regulatory warning
with regard to combining this vacuum drainage with the
roller pump? 
Dr LaPietra. No, we do not think that a regulatory warn-
ing is required. However, we do think that clinical neurocog-
nitive studies should be performed to evaluate the different
augmented venous drainage techniques being used.
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same experiments in a gravity sump system, including insert-
ing a 25-gauge needle, to prove that? 
Dr LaPietra. Even though the results of venous air han-
dling with conventional gravity siphon drainage are not pre-
sented, we have performed this part of the experiment in our
laboratory to verify the results that others have recently pub-
lished. Using a similar model as in the presented data, we
tested the venous air handling ability of gravity siphon
drainage. We have found that with an open 25-gauge needle
inserted into the venous line and a 40-cm height differential
between our simulated patient and the venous reservoir, less
air was introduced into the circuit, when compared with the
augmented systems. As mentioned earlier, we did not include
this part of the experiment in our paper since others have pub-
lished these results.
Dr Ludwig von Segesser (Lausanne, Switzerland). I think
it is important to state that it is not necessary to introduce air
into the venous line to have air in the system. It is enough to
have a clamp on the arterial side and maintain vacuum on the
venous side. The air will come through the oxygenator. 
Dr LaPietra. Thank you for your comments. Your point is
well taken, Dr von Segesser. Although this is absolutely true,
it is not a situation that would happen in a normal clinical set-
ting. Most of the components of the CPB circuit have been
evaluated in their air-handling abilities with special emphasis
on the oxygenator type and arterial pump type. Now we are
trying to build on some of these findings to evaluate how
these components behave under augmented assisted venous
drainage.
Dr Peter P. McKeown (Asheville, NC). I want to compli-
ment you on extending our understanding of CPB as we also
look at off-pump procedures. We have actually done away
with cardiotomy suction for most of the standard coronary
bypass operations. I guess that Shukri Khuri, Westaby, and
others have believed that the blood-air interface is a real prob-
lem. I wanted to ask about that. Did you actually just use the
cell salvage system? Also, did you use heparin-bonded cir-
cuits or heparin-bonded membranes? 
Dr LaPietra. Thank you, Dr McKeown. All of the circuits
that were constructed in this experiment consisted of heparin-
bonded tubing and membranes, such as we would normally
use in our clinical practice. However, we did not use any
blood components in our experiment, so the importance of
